MANAGING DIRECTOR EMPLOYMENT AGREEMENTManaging Director Employment Agreement • March 31st, 2009 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus
THIS MANAGING DIRECTOR EMPLOYMENT AGREEMENT (this “Agreement”) is made by and between LeMaitre Vascular GmbH., a German limited liability company with an address at Otto-Volger-Str 5 a/b, 65843 Sulzbach, Germany (the “Company”) and Peter R. Gebauer, an individual with a residence at Taubenweg 16, 61462 Koenigstein, Germany (the “Executive”) as of October 1, 2008.
FOURTH AMENDMENT OF LEASELease • March 31st, 2009 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus
THIS AMENDMENT made and entered into as of the 31st day of October, 2008 by and between Rodger P. Nordblom and Peter C. Nordblom, as Trustees of Northwest Associates (“Landlord”) and LeMaitre Vascular, Inc. (“Tenant”).
FIRST AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 31st, 2009 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Massachusetts
This First Amendment to Employment Agreement (“Amendment”) dated as of December 19, 2008 is made and entered into by and between LeMaitre Vascular, Inc., a Delaware corporation (the “Company”), and Joseph P. Pellegrino (the “Executive”).
FIRST AMENDMENT TO EXECUTIVE RETENTION AND SEVERANCE AGREEMENTExecutive Retention • March 31st, 2009 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Massachusetts
This First Amendment to Executive Retention and Severance Agreement (“Amendment”) dated as of December 23, 2008 is made and entered into by and between LeMaitre Vascular, Inc., a Delaware corporation (the “Company”), and George W. LeMaitre (the “Executive”).
FIRST AMENDMENT TO EXECUTIVE RETENTION AND SEVERANCE AGREEMENTExecutive Retention • March 31st, 2009 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Massachusetts
This First Amendment to Executive Retention and Severance Agreement (“Amendment”) dated as of December 19, 2008 is made and entered into by and between LeMaitre Vascular, Inc., a Delaware corporation (the “Company”), and David B. Roberts (the “Executive”).
